Roche’s $50Bn Bet On US Manufacturing: Tariff Shield But Cash Flow Strain
Analysts Warn That Such Large-Scale Investments Represent 10% Of Firm’s Market Capitalization
Roche is set to build a new manufacturing facility for continuous glucose monitoring (CGM) systems in Indiana. 
